What Is Driving Global Optical Genome Mapping Market Growth in 2025: The Role of Precision Medicine Driving Growth In The Optical Genome Mapping Market

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Optical Genome Mapping Market Size Growth Forecast: What to Expect by 2025?
The optical genome mapping sector has experienced a meteoric surge recently, projecting an expansion from a valuation of $0.17 billion in 2024 to $0.23 billion the following year, demonstrating a substantial compound annual growth rate (CAGR) of 29.3%. This upward trajectory during the review period stems from several key factors, including the escalating requirement for sophisticated genomic analysis methods, heightened investigations into identifying entire genomes on a large scale, a growing frequency of partnerships established between device producers and healthcare facilities, the integration of optical genome mapping within academic and biopharmaceutical organizations, and the inherent efficiency and cost benefits that facilitate the swift, precise examination of extensive genomes.

How Will the Optical Genome Mapping Market Size Evolve and Grow by 2029?
Anticipation surrounds the optical genome mapping market, projecting substantial expansion in the coming years, escalating to reach $0.6 billion by 2029, driven by a compound annual growth rate (CAGR) of 27.6%. This strong upward trajectory throughout the projection timeframe is underpinned by several factors, including progress in genomic investigation, a growing need for highly individualized medical treatments, escalating financial support and programmatic efforts from governmental bodies, well-developed healthcare systems, and a higher incidence rate of both inheritable disorders and malignancies. Key developments shaping this period involve sophistication in OGM offerings, momentum in genomic study projects, improvements in DNA charting methods, broader technological improvements, and enhancements in computational techniques like artificial intelligence and machine learning applied to genomic information handling.

View the full report here:
https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report

What Drivers Are Propelling the Growth of Optical Genome Mapping Market Forward?
Anticipation of a surge in the need for precision medicine is projected to fuel the expansion of the optical genome mapping market moving ahead. This personalized healthcare methodology tailors medical interventions and preventative measures based on individual elements like genetic structure, habits, and surroundings. The rising impetus behind precision medicine stems from the growing incidence of long-term illnesses, progress in genetic sequencing technologies, heightened financial backing, and patients' desire for care tailored specifically to them. Optical genome mapping significantly bolsters precision medicine's effectiveness by offering an in-depth and precise apprehension of the genetic changes linked to a spectrum of ailments. As an illustration, data from the Personalized Medicine Coalition, a US non-profit entity, indicated that in 2023, the FDA authorized a total of 16 new personalized treatments aimed at individuals suffering from rare conditions, a notable increase from the six approvals documented in 2022. Consequently, the expanding requirement for precision medicine serves as a key catalyst for the advancement of the optical genome mapping market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp

Which Emerging Trends Are Transforming the Optical Genome Mapping Market in 2025?
Leading enterprises participating in the optical genome mapping sector are focusing on creating laboratory-developed tests (LDTs) that leverage optical genome mapping technology with the goal of refining diagnostic precision and delivering superior genomic information. These OGM-based LDTs represent diagnostic procedures conceived and executed solely within distinct clinical lab settings using the optical genome mapping (OGM) platform. As an illustration, in September 2022, Bionano Genomics Inc., an American firm specializing in genome analysis software, introduced an optical genome mapping LDT specifically for diagnosing facioscapulohumeral muscular dystrophy (FSHD). This technology-driven LDT will subsequently permit Bionano Laboratories to provide services to various clients-including medical centers, drug manufacturers, and other organizations-who intend to incorporate OGM into their standard diagnostic procedures and research endeavors.

What Are the Key Segments in the Optical Genome Mapping Market?
The optical genome mappingmarket covered in this report is segmented -

1) By Product: Instruments; Consumables And Reagents; Software; Services
2) By Application: Structural Variant Detection; Genome Assembly; Microbial Strain Typing; Other Applications
3) By End-User: Biotechnology And Pharmaceutical Companies; Clinical Laboratories; Academic Research Institutes; Other End-Users

Subsegments:
1) By Instruments: Optical Genome Mapping Systems; Imaging Systems; Detection And Analysis Devices
2) By Consumables And Reagents: DNA Preparation Kits; Labeling Reagents; Flow Cells
3) By Software: Data Analysis Software; Image Processing Software; Mapping Software
4) By Services: Data Analysis Services; Technical Support Services; Training And Consultation Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15882&type=smp

Who Are the Key Players Shaping the Optical Genome Mapping Market's Competitive Landscape?
Major companies operating in the optical genome mapping market are Agilent Technologies Inc., Illumina Inc., PerkinElmer Genomics, Bio-Rad Laboratories Inc., Qiagen N.V., Cerba Healthcare, GenScript Biotech Corporation, 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., NanoString Technologies Inc., MedGenome, Element Biosciences, Bionano Genomics Inc., Stratos Genomics, BioSkryb Genomics, Source Genomics, Genoox, Nucleome Informatics Private Limited, Praxis Genomics LLC, Phase Genomics Inc., Daicel Arbor Biosciences, Nabsys, OpGen, Genohub Inc.

What Geographic Markets Are Powering Growth in the Optical Genome Mapping Market?
North America was the largest region in the optical genome mapping market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15882

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.